UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047136 |
|---|---|
| Receipt number | R000053735 |
| Scientific Title | A prospective study on the prevalence and clinical presentation of JAK2 V617F mutation in patients with cerebral infarction. |
| Date of disclosure of the study information | 2022/03/10 |
| Last modified on | 2025/03/12 18:16:20 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A prospective study on the prevalence and clinical presentation of JAK2 V617F mutation in patients with cerebral infarction.
Acronym
A prospective study on the prevalence and clinical presentation of JAK2 V617F mutation in patients with cerebral infarction.
Scientific Title
A prospective study on the prevalence and clinical presentation of JAK2 V617F mutation in patients with cerebral infarction.
Scientific Title:Acronym
A prospective study on the prevalence and clinical presentation of JAK2 V617F mutation in patients with cerebral infarction.
Region
| Japan |
Condition
Condition
Cerebral infarction
Classification by specialty
| Hematology and clinical oncology | Neurology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the prevalence and clinical features of JAK2V617F mutation in patients with cerebral infarction
Basic objectives2
Others
Basic objectives -Others
To investigate the clinical characteristics of patients with stroke who are positive for the JAK2V617F mutation.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prevalence of JAK2V617F mutation in patients with cerebral infarction
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | < |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients admitted to our department, within 7 days of stroke onset
Key exclusion criteria
Patients whose consent cannot be obtained. Patients whose physicians consider them inappropriate due to poor medical conditions.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Yasuhiro |
| Middle name | |
| Last name | Nishiyama |
Organization
Nippon Medical School
Division name
Neurology
Zip code
113-8603
Address
1-1-5 Sendagi, Bunkyo-ku, Tokyo
TEL
+81-3-3822-2131
toshi-h-06@nms.ac.jp
Public contact
Name of contact person
| 1st name | Toshiyuki |
| Middle name | |
| Last name | Hayashi |
Organization
Nippon Medical School
Division name
Neurology
Zip code
113-8603
Address
1-1-5 Sendagi, Bunkyo-ku, Tokyo
TEL
+81-3-3822-2131
Homepage URL
toshi-h-06@nms.ac.jp
Sponsor or person
Institute
Nippon Medical School
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Nippon Medical School
Address
1-1-5 Sendagi, Bunkyo-ku, Tokyo
Tel
+81-3-3822-2131
toshi-h-06@nms.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 03 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
1009
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2021 | Year | 03 | Month | 22 | Day |
Date of IRB
| 2021 | Year | 03 | Month | 22 | Day |
Anticipated trial start date
| 2022 | Year | 01 | Month | 20 | Day |
Last follow-up date
| 2024 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2022 | Year | 03 | Month | 10 | Day |
Last modified on
| 2025 | Year | 03 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053735
